These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 36122897)
41. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Norman J; Madurawe RD; Moore CM; Khan MA; Khairuzzaman A Adv Drug Deliv Rev; 2017 Jan; 108():39-50. PubMed ID: 27001902 [TBL] [Abstract][Full Text] [Related]
42. Investigation of the degradation and in-situ amorphization of the enantiomeric drug escitalopram oxalate during Fused Deposition Modeling (FDM) 3D printing. Hoffmann L; Breitkreutz J; Quodbach J Eur J Pharm Sci; 2023 Jun; 185():106423. PubMed ID: 36918059 [TBL] [Abstract][Full Text] [Related]
43. 3D printing of tablets using inkjet with UV photoinitiation. Clark EA; Alexander MR; Irvine DJ; Roberts CJ; Wallace MJ; Sharpe S; Yoo J; Hague RJM; Tuck CJ; Wildman RD Int J Pharm; 2017 Aug; 529(1-2):523-530. PubMed ID: 28673860 [TBL] [Abstract][Full Text] [Related]
44. 3D printing of high drug loaded dosage forms using thermoplastic polyurethanes. Verstraete G; Samaro A; Grymonpré W; Vanhoorne V; Van Snick B; Boone MN; Hellemans T; Van Hoorebeke L; Remon JP; Vervaet C Int J Pharm; 2018 Jan; 536(1):318-325. PubMed ID: 29217471 [TBL] [Abstract][Full Text] [Related]
45. 3D screen printing technology enables fabrication of oral drug dosage forms with freely tailorable release profiles. Enke M; Schwarz N; Gruschwitz F; Winkler D; Hanf F; Jescheck L; Seyferth S; Fischer D; Schneeberger A Int J Pharm; 2023 Jul; 642():123101. PubMed ID: 37295568 [TBL] [Abstract][Full Text] [Related]
46. An Intragastric Delivery Device Employing FDM Technology: 3D-Printed Tablet Containing Green Developed Mosapride-Saccharin Co-crystals. Amin OM; El Qady HN; Abd El-Fattah MA AAPS PharmSciTech; 2023 Jun; 24(5):127. PubMed ID: 37264247 [TBL] [Abstract][Full Text] [Related]
47. Channelled tablets: An innovative approach to accelerating drug release from 3D printed tablets. Sadia M; Arafat B; Ahmed W; Forbes RT; Alhnan MA J Control Release; 2018 Jan; 269():355-363. PubMed ID: 29146240 [TBL] [Abstract][Full Text] [Related]
48. Pharmaceutical applications of powder-based binder jet 3D printing process - A review. Sen K; Mehta T; Sansare S; Sharifi L; Ma AWK; Chaudhuri B Adv Drug Deliv Rev; 2021 Oct; 177():113943. PubMed ID: 34450238 [TBL] [Abstract][Full Text] [Related]
49. 3D-Printed Oral Dosage Forms: Mechanical Properties, Computational Approaches and Applications. Karalia D; Siamidi A; Karalis V; Vlachou M Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575475 [TBL] [Abstract][Full Text] [Related]
50. The potential of three-dimensional printing for pediatric oral solid dosage forms. Kreft K; Fanous M; Möckel V Acta Pharm; 2024 Jun; 74(2):229-248. PubMed ID: 38815205 [TBL] [Abstract][Full Text] [Related]
51. Design and characterization of a novel 3D printed pressure-controlled drug delivery system. Krause J; Bogdahn M; Schneider F; Koziolek M; Weitschies W Eur J Pharm Sci; 2019 Dec; 140():105060. PubMed ID: 31499171 [TBL] [Abstract][Full Text] [Related]
52. 3D extrusion printing of high drug loading immediate release paracetamol tablets. Khaled SA; Alexander MR; Wildman RD; Wallace MJ; Sharpe S; Yoo J; Roberts CJ Int J Pharm; 2018 Mar; 538(1-2):223-230. PubMed ID: 29353082 [TBL] [Abstract][Full Text] [Related]
53. Fused deposition modeling 3D printing of solid oral dosage forms containing amorphous solid dispersions: How to elucidate drug dissolution mechanisms through surface spectral analysis techniques? Parulski C; Gresse E; Jennotte O; Felten A; Ziemons E; Lechanteur A; Evrard B Int J Pharm; 2022 Oct; 626():122157. PubMed ID: 36055443 [TBL] [Abstract][Full Text] [Related]
55. A critical review of traditional and advanced characterisation tools to drive formulators towards the rational development of 3D printed oral dosage forms. Deon M; Dos Santos J; de Andrade DF; Beck RCR Int J Pharm; 2022 Nov; 628():122293. PubMed ID: 36252640 [TBL] [Abstract][Full Text] [Related]
56. Thermal Extrusion 3D Printing for the Fabrication of Puerarin Immediate-Release Tablets. Li P; Jia H; Zhang S; Yang Y; Sun H; Wang H; Pan W; Yin F; Yang X AAPS PharmSciTech; 2019 Dec; 21(1):20. PubMed ID: 31820224 [TBL] [Abstract][Full Text] [Related]
57. Extrusion 3D Printing of Paracetamol Tablets from a Single Formulation with Tunable Release Profiles Through Control of Tablet Geometry. Khaled SA; Alexander MR; Irvine DJ; Wildman RD; Wallace MJ; Sharpe S; Yoo J; Roberts CJ AAPS PharmSciTech; 2018 Nov; 19(8):3403-3413. PubMed ID: 30097806 [TBL] [Abstract][Full Text] [Related]
58. Influence of the geometry of 3D printed solid oral dosage forms on their swallowability. Bogdahn M; Torner J; Krause J; Grimm M; Weitschies W Eur J Pharm Biopharm; 2021 Oct; 167():65-72. PubMed ID: 34298113 [TBL] [Abstract][Full Text] [Related]
59. A Proof of Concept for 3D Printing of Solid Lipid-Based Formulations of Poorly Water-Soluble Drugs to Control Formulation Dispersion Kinetics. Vithani K; Goyanes A; Jannin V; Basit AW; Gaisford S; Boyd BJ Pharm Res; 2019 May; 36(7):102. PubMed ID: 31098846 [TBL] [Abstract][Full Text] [Related]
60. 3D-printed dosage forms for oral administration: a review. Pan S; Ding S; Zhou X; Zheng N; Zheng M; Wang J; Yang Q; Yang G Drug Deliv Transl Res; 2024 Feb; 14(2):312-328. PubMed ID: 37620647 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]